Clinical Trial Update: Hydroxychloroquine in Treating Patients With Newly Diagnosed Chronic Graft-Versus-Host Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating hydroxychloroquine for newly diagnosed chronic graft-versus-host disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Children's Oncology Group | Conditions: Graft Versus Host Disease | Phase 3 | Status: COMPLETED